Otsuka Pharmaceutical
Japan-based a pharmaceutical company.
Launch date
Employees
Market cap
CAD45.6b
Enterprise valuation
CAD42.0b (Public information from Sep 2024)
Share price
JPY7953 4578.T
Tokyo Japan (HQ)
Financials
Estimates*
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.4t | 1.5t | 1.7t | 2.0t | 2.3t | 2.3t | 2.3t |
| % growth | 2 % | 5 % | 16 % | 16 % | 12 % | - | - |
| EBITDA | 307.8b | 259.8b | 314.3b | 419.4b | 458.3b | 469.1b | 424.6b |
| % EBITDA margin | 22 % | 17 % | 18 % | 21 % | 20 % | 21 % | 19 % |
| Profit | 148.1b | 125.5b | 134.0b | 121.6b | 225.6b | 259.0b | 235.0b |
| % profit margin | 10 % | 8 % | 8 % | 6 % | 10 % | 11 % | 10 % |
| EV / revenue | 1.6x | 1.3x | 1.2x | 1.2x | 1.9x | 1.8x | 1.7x |
| EV / EBITDA | 7.2x | 7.6x | 6.5x | 6.0x | 9.2x | 8.6x | 9.1x |
| R&D budget | 216.8b | 232.3b | 275.2b | 307.8b | - | - | - |
| R&D % of revenue | 15 % | 16 % | 16 % | 15 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Otsuka Pharmaceutical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Otsuka Pharmaceutical
Edit
ACQUISITION by Otsuka Pharmaceutical Dec 2020
ACQUISITION by Otsuka Pharmaceutical Jul 2018
ACQUISITION by Otsuka Pharmaceutical Jul 2018
ACQUISITION by Otsuka Pharmaceutical Aug 2024
